Mp Biomedicals India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.20 M
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.00 Cr
- Revenue Growth -47.84%
- Profit Growth -117.79%
- Ebitda -142.90%
- Net Worth -4.53%
- Total Assets 17.79%
About Mp Biomedicals India
Mp Biomedicals India Private Limited (MBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 April 2009 and has a history of 15 years and ten months. Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.20 M.
The company has closed loans amounting to ₹4.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rahul Tewari and Du Yang serve as directors at the Company.
Company Details
- Location Navi Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100MH2009PTC191394
- Company No.
191394
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Mp Biomedicals India Private Limited offer?
Mp Biomedicals India Private Limited offers a wide range of products and services, including Chemical Test Kits, Tris Buffer Solution, Chemical Reagents & Catalysts, Inorganic Salts, Cosmetics, Hair & Beauty Products, Cosmetic Chemical, Fatty Esters, Oxidizing Agent, Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Mp Biomedicals India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Tewari  | Director | 06-Aug-2024 | Current |
Du Yang  | Director | 12-Aug-2019 | Current |
Financial Performance of Mp Biomedicals India.
Mp Biomedicals India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 47.84% decrease. The company also saw a substantial fall in profitability, with a 117.79% decrease in profit. The company's net worth dipped by a decrease of 4.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mp Biomedicals India?
In 2023, Mp Biomedicals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹4.00 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2016 | Bank Of India | ₹4.00 Cr | Satisfied |
How Many Employees Work at Mp Biomedicals India?
Unlock and access historical data on people associated with Mp Biomedicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mp Biomedicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mp Biomedicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
